Izidore Lossos, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL) (NCT06796998) | Izidore Lossos, MD | 2025-10-13 |
| Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (NCT06569680) | Izidore Lossos, MD | 2024-11-19 |
Track Izidore Lossos, MD automatically
Every clearance here is in the API, with alerts when new ones post.